RESUMEN

Homocyst(e)ine (Hcy) inhibits the expression of the antioxidant enzyme cellular glutathione peroxidase (GPx-1) in vitro and in vivo, which can lead to an increase in reactive oxygen species that inactivate NO and promote endothelial dysfunction. In this study, we tested the hypothesis that overexpression of GPx-1 can restore the normal endothelial phenotype in hyperhomocyst(e)inemic states. Heterozygous cystathionine beta-synthase-deficient (CBS((-/+))) mice and their wild-type littermates (CBS((+/+))) were crossbred with mice that overexpress GPx-1 [GPx-1((tg+)) mice]. GPx-1 activity was 28% lower in CBS((-/+))/GPx-1((tg-)) compared with CBS((+/+))/GPx-1((tg-)) mice (P < 0.05), and CBS((-/+)) and CBS((+/+)) mice overexpressing GPx-1 had 1.5-fold higher GPx-1 activity compared with GPx-1 nontransgenic mice (P < 0.05). Mesenteric arterioles of CBS((-/+))/GPx-1((tg-)) mice showed vasoconstriction to superfusion with beta-methacholine and bradykinin (P < 0.001 vs. all other groups), whereas nonhyperhomocyst(e)inemic mice [CBS((+/+))/GPx-1((tg-)) and CBS((+/+))/GPx-1((tg+)) mice] demonstrated dose-dependent vasodilation in response to both agonists. Overexpression of GPx-1 in hyperhomocyst(e)inemic mice restored the normal endothelium-dependent vasodilator response. Bovine aortic endothelial cells (BAEC) were transiently transfected with GPx-1 and incubated with dl-homocysteine (HcyH) or l-cysteine. HcyH incubation decreased GPx-1 activity in sham-transfected BAEC (P < 0.005) but not in GPx-1-transfected cells. Nitric oxide release from BAEC was significantly decreased by HcyH but not cysteine, and GPx-1 overexpression attenuated this decrease. These findings demonstrate that overexpression of GPx-1 can compensate for the adverse effects of Hcy on endothelial function and suggest that the adverse vascular effects of Hcy are at least partly mediated by oxidative inactivation of NO.

Asunto(s)

Endotelio Vascular/efectos de los fármacos , Glutatión Peroxidasa/fisiología , Homocisteína/toxicidad , Animales , Células Cultivadas , AMP Cíclico/biosíntesis , Cistationina betasintasa/fisiología , Endotelio Vascular/fisiología , Ratones , Ratones Transgénicos , Óxido Nítrico/biosíntesis , Óxido Nítrico Sintasa/metabolismo , Óxido Nítrico Sintasa de Tipo II , Óxido Nítrico Sintasa de Tipo III

RESUMEN

Enhanced phosphorylation of the ribosomal protein s6 kinase, p70(s6k), and the translational repressor, 4E-BP1, are associated with either insulin-induced or amino acid-induced protein synthesis. Hyperphosphorylation of p70(s6k) and 4E-BP1 in response to insulin or amino acids is mediated through the mammalian target of rapamycin (mTOR). In several cell lines, mTOR or its downstream targets can be regulated by phosphatidylinositol (PI) 3-kinase; protein kinases A, B, and C; heterotrimeric G-proteins; a PD98059-sensitive kinase or calcium; as well as by amino acids. Regulation by amino acids appears to involve detection of levels of charged t-RNA or t-RNA synthetase activity and is sensitive to inhibition by amino acid alcohols. In the present article, however, we show that the rapamycin-sensitive regulation of 4E-BP1 and p70(s6k) in freshly isolated rat adipocytes is not inhibited by either L-leucinol or L-histidinol. This finding is in agreement with other recent studies from our laboratory suggesting that the mechanism by which amino acids regulate mTOR in freshly isolated adipocytes may be different than the mechanism found in a number of cell lines. Therefore we investigated the possible role of growth factor-regulated and G-protein-regulated signaling pathways in the rapamycin-sensitive, amino acid alcohol-insensitive actions of amino acids on 4E-BP1 phosphorylation. We found, in contrast to previously published results using 3T3-L1 adipocytes or other cell lines, that the increase in 4E-BP1 phosphorylation promoted by amino acids was insensitive to agents that regulate protein kinase A, mobilize calcium, or inhibit protein kinase C. Furthermore, amino acid-induced 4E-BP1 phosphorylation was not blocked by pertussis toxin nor was it mimicked by the G-protein agonists fluoroaluminate or MAS-7. However, amino acids failed to activate either PI 3-kinase, protein kinase B, or mitogen-activated protein kinase and failed to promote tyrosine phosphorylation of cellular proteins, similar to observations made using cell lines. In summary, amino acids appear to use an amino acid alcohol-insensitive mechanism to regulate mTOR in freshly isolated adipocytes. This mechanism is independent of cell-signaling pathways implicated in the regulation of mTOR or its downstream targets in other cells. Overall, our study emphasizes the need for caution when extending results obtained using established cell lines to the differentiated nondividing cells found in most tissues.

Asunto(s)

Adipocitos/efectos de los fármacos , Aminoácidos/farmacología , Proteínas Portadoras , Fosfotransferasas (Aceptor de Grupo Alcohol)/biosíntesis , Proteínas Serina-Treonina Quinasas , Transducción de Señal/efectos de los fármacos , Adenosina Difosfato Ribosa/metabolismo , Adipocitos/metabolismo , Aluminio/farmacología , Animales , Células Cultivadas/efectos de los fármacos , Células Cultivadas/metabolismo , Inhibidores Enzimáticos/farmacología , Flúor/farmacología , Subunidades alfa de la Proteína de Unión al GTP Gi-Go/metabolismo , Histidinol/farmacología , Insulina/farmacología , Péptidos y Proteínas de Señalización Intracelular , Leucina/análogos & derivados , Leucina/farmacología , Masculino , Proteínas Quinasas Activadas por Mitógenos/metabolismo , Toxina del Pertussis , Fosfatidilinositol 3-Quinasas/metabolismo , Fosfoproteínas/metabolismo , Fosforilación/efectos de los fármacos , Fosfotransferasas (Aceptor de Grupo Alcohol)/genética , Proteínas Quinasas/metabolismo , Procesamiento Proteico-Postraduccional/efectos de los fármacos , Proteínas Proto-Oncogénicas/metabolismo , Proteínas Proto-Oncogénicas c-akt , Ratas , Ratas Sprague-Dawley , Proteínas Quinasas S6 Ribosómicas , Sirolimus/farmacología , Estaurosporina/farmacología , Serina-Treonina Quinasas TOR , Factores de Virulencia de Bordetella/farmacología

RESUMEN

Homocysteine is a risk factor for the development of atherosclerosis and its thrombotic complications. We have employed an animal model to explore the hypothesis that an increase in reactive oxygen species and a subsequent loss of nitric oxide bioactivity contribute to endothelial dysfunction in mild hyperhomocysteinemia. We examined endothelial function and in vivo oxidant burden in mice heterozygous for a deletion in the cystathionine beta-synthase (CBS) gene, by studying isolated, precontracted aortic rings and mesenteric arterioles in situ. CBS(-/+) mice demonstrated impaired acetylcholine-induced aortic relaxation and a paradoxical vasoconstriction of mesenteric microvessels in response to superfusion of methacholine and bradykinin. Cyclic GMP accumulation following acetylcholine treatment was also impaired in isolated aortic segments from CBS(-/+) mice, but aortic relaxation and mesenteric arteriolar dilation in response to sodium nitroprusside were similar to wild-type. Plasma levels of 8-epi-PGF(2alpha) (8-IP) were somewhat increased in CBS(-/+) mice, but liver levels of 8-IP and phospholipid hydroperoxides, another marker of oxidative stress, were normal. Aortic tissue from CBS(-/+) mice also demonstrated greater superoxide production and greater immunostaining for 3-nitrotyrosine, particularly on the endothelial surface. Importantly, endothelial dysfunction appears early in CBS(-/+) mice in the absence of structural arterial abnormalities. Hence, mild hyperhomocysteinemia due to reduced CBS expression impairs endothelium-dependent vasodilation, likely due to impaired nitric oxide bioactivity, and increased oxidative stress apparently contributes to inactivating nitric oxide in chronic, mild hyperhomocysteinemia.

Asunto(s)

Endotelio Vascular/fisiopatología , Hiperhomocisteinemia/fisiopatología , Acetilcolina/farmacología , Animales , Aorta/efectos de los fármacos , Aorta/patología , Aorta/fisiopatología , Arteriosclerosis/etiología , Cistationina betasintasa/genética , Cistationina betasintasa/metabolismo , Dinoprost/análogos & derivados , Dinoprost/metabolismo , Modelos Animales de Enfermedad , F2-Isoprostanos , Heterocigoto , Humanos , Hiperhomocisteinemia/genética , Hiperhomocisteinemia/patología , Técnicas In Vitro , Peróxidos Lipídicos/metabolismo , Ratones , Ratones Mutantes , Nitroprusiato/farmacología , Especies Reactivas de Oxígeno/metabolismo , Factores de Riesgo , Trombosis/etiología , Tirosina/análogos & derivados , Tirosina/metabolismo , Vasodilatación/efectos de los fármacos

RESUMEN

Although nitric oxide (NO) has potent antiplatelet actions, the signaling pathways affected by NO in the platelet are poorly understood. Since NO can induce platelet disaggregation and phosphoinositide 3-kinase (PI3-kinase) activation renders aggregation irreversible, we tested the hypothesis that NO exerts its antiplatelet effects at least in part by inhibiting PI3-kinase. The results demonstrate that the NO donor S-nitrosoglutathione (S-NO-glutathione) inhibits the stimulation of PI3-kinase associated with tyrosine-phosphorylated proteins and of p85/PI3-kinase associated with the SRC family kinase member LYN following the exposure of platelets to thrombin receptor-activating peptide. The activation of LYN-associated PI3-kinase was unrelated to changes in the amount of PI3-kinase physically associated with LYN signaling complexes but did require the activation of LYN and other tyrosine kinases. The cyclic GMP-dependent kinase activator 8-bromo-cyclic GMP had similar effects on PI3-kinase activity, consistent with a model in which the cyclic nucleotide mediates the effects of NO. Additional studies showed that wortmannin and S-NO-glutathione have additive inhibitory effects on thrombin receptor-activating peptide-induced platelet aggregation and the surface expression of platelet activation markers. These data provide evidence of a distinct and novel mechanism for the inhibitory effects of NO on platelet function.

Asunto(s)

Plaquetas/enzimología , Óxido Nítrico/farmacología , Fragmentos de Péptidos/metabolismo , Fosfatidilinositol 3-Quinasas/metabolismo , Inhibidores de Agregación Plaquetaria/farmacología , Receptores de Trombina/metabolismo , Androstadienos/farmacología , Plaquetas/efectos de los fármacos , Células Cultivadas , Glutatión/metabolismo , Humanos , Agregación Plaquetaria/efectos de los fármacos , Wortmanina , Familia-src Quinasas/metabolismo

RESUMEN

Sustained hyperglycemia impairs insulin-stimulated glucose utilization in the skeletal muscle of both humans and experimental animals--a phenomenon referred to clinically as glucose toxicity. To study how this occurs, a model was developed in which hyperglycemia produces insulin resistance in vitro. Rat extensor digitorum longus muscles were preincubated for 4 h in Krebs-Henseleit solution containing glucose or glucose + insulin at various concentrations, after which insulin action was studied. Preincubation with 25 mmol/l glucose + insulin (10 mU/ml) led to a 70% decrease in the ability of insulin (10 mU/ml) to stimulate glucose incorporation into glycogen and a 30% decrease in 2-deoxyglucose (2-DG) uptake, compared with muscles incubated with 0 mmol/l glucose. Glucose incorporation into lipid and its oxidation to CO2 were marginally diminished, if at all. The alterations of glycogen synthesis and 2-DG uptake were first evident after 1 h and were maximal after 2 h of preincubation; they were not observed in muscles preincubated with 25 mmol/l glucose + insulin for 5 min. Preincubation for 4 h with 25 mmol/l glucose in the absence of insulin produced a similar although somewhat smaller decrease in insulin-stimulated glycogen synthesis; however, it did not alter 2-DG uptake, glucose oxidation to CO2, or incorporation into lipids. Studies of insulin signaling in the latter muscles revealed that activation of Akt/protein kinase B (PKB) was diminished by 60%, compared with that of muscles preincubated in a glucose-free medium; whereas activation of phosphatidylinositol (PI) 3-kinase, an upstream regulator of Akt/PKB in the insulin-signaling cascade, and of mitogen-activated protein (MAP) kinase, a parallel signal, was unaffected. Immunoblots demonstrated that this was not due to a change in Akt/PKB abundance. The results indicate that hyperglycemia-induced insulin resistance can be studied in rat skeletal muscle in vitro. They suggest that impairment of insulin action in these muscles is related to inhibition of Akt/PKB by events that do not affect PI 3-kinase.

Asunto(s)

Hiperglucemia/enzimología , Insulina/farmacología , Músculo Esquelético/metabolismo , Fosfatidilinositol 3-Quinasas/metabolismo , Proteínas Serina-Treonina Quinasas , Proteínas Proto-Oncogénicas/metabolismo , Animales , Proteínas Quinasas Dependientes de Calcio-Calmodulina/metabolismo , Desoxiglucosa/metabolismo , Activación Enzimática , Glucosa/farmacología , Glucógeno/biosíntesis , Técnicas In Vitro , Cinética , Masculino , Proteína Quinasa 1 Activada por Mitógenos , Músculo Esquelético/efectos de los fármacos , Músculo Esquelético/enzimología , Inhibidores de las Quinasa Fosfoinosítidos-3 , Proteínas Tirosina Quinasas/metabolismo , Proteínas Proto-Oncogénicas/antagonistas & inhibidores , Proteínas Proto-Oncogénicas c-akt , Ratas , Ratas Sprague-Dawley

RESUMEN

Lysophosphatidic acid (LPA) is the smallest and structurally simplest of all the glycerophospholipids. It occurs normally in serum and binds with high affinity to albumin, while retaining its biological activity. The effects of LPA are pleiotropic and range from mitogenesis to stress fiber formation. We show a novel role for LPA: as a macrophage survival factor with potency equivalent to serum. Administration of LPA protects macrophages from apoptosis induced by serum deprivation, and protection is equivalent to that with conventional survival factors such as macrophage colony stimulating factor. The ability of LPA to act as a survival factor is mediated by the lipid kinase phosphatidylinositol 3-kinase (PI3K), since LPA activated both the p85-p110 and p110gamma isoforms of PI3K and macrophage survival was blocked completely by wortmannin or LY294002, two mechanistically dissimilar inhibitors of PI3K. pp70(s6k), a downstream kinase activated by PI3K, also contributes to survival, because inhibitors of pp70(s6k), such as rapamycin, blocked macrophage survival in the presence of LPA. Modified forms of LPA and phospholipids, such as phosphatidylcholine and phosphatidylethanolamine, had no survival effect, thereby showing the specificity of LPA. These results show that LPA acts as a potent macrophage survival factor. Based on striking similarities between our LPA and serum data, we suggest that LPA is a major noncytokine survival factor in serum.

Asunto(s)

Lisofosfolípidos/farmacología , Macrófagos Peritoneales/efectos de los fármacos , Fosfatidilinositol 3-Quinasas/metabolismo , Androstadienos/farmacología , Animales , Apoptosis/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Cromonas/farmacología , Medio de Cultivo Libre de Suero , Lisofosfolípidos/sangre , Macrófagos Peritoneales/citología , Ratones , Ratones Endogámicos BALB C , Morfolinas/farmacología , Inhibidores de las Quinasa Fosfoinosítidos-3 , Polienos/farmacología , Proteínas Quinasas S6 Ribosómicas/antagonistas & inhibidores , Transducción de Señal/efectos de los fármacos , Sirolimus , Suramina/farmacología , Wortmanina

Asunto(s)

Resistencia a la Insulina , Metabolismo de los Lípidos , Malonil Coenzima A/metabolismo , Músculo Esquelético/metabolismo , Animales , Roedores

RESUMEN

Insulin and IGF-I induced a similar stimulation of glucose transport in isolated soleus muscle. These actions require phosphatidylinositol (PI) 3-kinase activation since the PI 3-kinase inhibitor, wortmannin, blocked the stimulation by both peptides. We compared IGF-I with insulin in the ability to activate PI 3-kinase in the isolated soleus muscle from lean and gold thioglucose-induced obese insulin-resistant mice. In muscles from lean mice, IGF-I and insulin were able to activate PI 3-kinase with a similar time course, the effects being maximal within 3-5 min of stimulation. However, the IGF-I concentrations required to obtain similar effects on PI 3-kinase were about 10 times higher than the corresponding insulin doses. To determine through which receptor IGF-I was activating PI 3-kinase, the ability of IGF-I to activate both its own receptor and insulin receptor was simultaneously measured. Whatever the dose used (100 or 500 nmol/l), IGF-I activated to a nearly similar extent both the tyrosine kinase activity of its own receptor and that of the insulin receptor, suggesting that IGF-I was not only activating its receptor but was also able to stimulate the insulin receptor kinase. In muscles of obese insulin-resistant mice, although the defect of PI 3-kinase activation in response to IGF-I was relatively less pronounced (45%) than in response to insulin (70%) when compared with lean mice, PI 3-kinase stimulation was still markedly altered in response to IGF-I.

Asunto(s)

Resistencia a la Insulina , Factor I del Crecimiento Similar a la Insulina/farmacología , Insulina/farmacología , Músculo Esquelético/enzimología , Obesidad/enzimología , Fosfotransferasas (Aceptor de Grupo Alcohol)/metabolismo , Proteínas Tirosina Quinasas Receptoras/metabolismo , Androstadienos/farmacología , Animales , Aurotioglucosa , Glucemia/metabolismo , Peso Corporal , Inhibidores Enzimáticos/farmacología , Masculino , Ratones , Obesidad/inducido químicamente , Fosfatidilinositol 3-Quinasas , Fosfotransferasas (Aceptor de Grupo Alcohol)/antagonistas & inhibidores , Valores de Referencia , Wortmanina

RESUMEN

The mechanisms underlying insulin and insulin-like growth factor-I (IGF-I) action on glucose transport share similar processes leading to Glut 4 translocation after respective receptor activation. Among these steps are phosphorylation of insulin receptor substrate-1 (IRS-1) and activation of phosphatidylinositol-3-kinase (P13-kinase). This enzyme could be involved in stimulated glucose transport in muscle, since its inhibitor, wortmannin, blocks the hormonal effect in muscle. P13-kinase is activated by insulin and IGF-I in a rapid and transient manner in incubated soleus muscles. When P13-kinase activation was studied in muscle of obese insulin-resistant mice, there was a marked alteration in the response to insulin both in vivo and in vitro. P13-kinase activation by IGF-I was also altered in obese mice, although to a lesser degree.

Asunto(s)

Glucosa/metabolismo , Factor I del Crecimiento Similar a la Insulina/farmacología , Insulina/farmacología , Proteínas de Transporte de Monosacáridos/metabolismo , Músculo Esquelético/metabolismo , Obesidad/metabolismo , Animales , Transporte Biológico/efectos de los fármacos , Activación Enzimática/efectos de los fármacos , Miembro Posterior , Masculino , Ratones , Ratones Endogámicos , Músculo Esquelético/efectos de los fármacos , Fosfatidilinositol 3-Quinasas , Fosfotransferasas (Aceptor de Grupo Alcohol)/metabolismo , Valores de Referencia

RESUMEN

The activation of phosphatidylinositol 3-kinase (PIK) was studied in vivo and in vitro in soleus muscle and adipocytes from young (8 wk) and old (30 wk) gold thioglucose obese mice. Insulin resistance assessed from muscle glucose transport and glycogen synthesis was present both in young and old obese mice. Adipocyte lipid synthesis and muscle glycolysis or glucose oxidation are not defective in young obese mice but become resistant later on. After incubation with 50 nM insulin, muscle antiphosphotyrosine-immunoprecipitable PIK activity was stimulated 5- to 10-fold in both young and old animals. This response was impaired by 56 and 75% in muscles from young and old obese mice, respectively. Insulin stimulation of receptor tyrosine kinase activity was only slightly decreased in muscle of young obese mice, whereas insulin receptor substrate 1 (IRS-1) tyrosine phosphorylation was blunted. The altered PIK stimulation in muscle, which is present both in vivo and in vitro, is thus characterized by a reduced association of PIK activity with IRS-1 and appears to result from a diminished IRS-1 tyrosine phosphorylation. In adipocytes isolated from lean mice, antiphosphotyrosine-immunoprecipitable PIK increased 25-fold within 10 min of incubation with insulin. This stimulation was markedly altered both in young and old obese mice, whereas lipogenesis was insulin resistant only in old obese animals. In adipocytes from young obese mice, insulin's stimulatory effect on the phosphorylation of insulin receptor beta-subunit, pp60, and an exogenous substrate was normal, whereas IRS-1 tyrosine phosphorylation was markedly depressed.(ABSTRACT TRUNCATED AT 250 WORDS)

Asunto(s)

Adipocitos/enzimología , Insulina/farmacología , Músculos/enzimología , Obesidad/enzimología , Fosfotransferasas (Aceptor de Grupo Alcohol)/metabolismo , Tejido Adiposo/enzimología , Animales , Aurotioglucosa , Transporte Biológico , Epidídimo , Glucosa/metabolismo , Masculino , Ratones , Ratones Endogámicos , Proteínas Musculares/metabolismo , Músculo Esquelético/enzimología , Obesidad/inducido químicamente , Fosfatidilinositol 3-Quinasas , Fosforilación , Proteínas Tirosina Quinasas Receptoras/metabolismo , Tirosina/metabolismo

Asunto(s)

Tejido Adiposo/metabolismo , Resistencia a la Insulina , Músculo Esquelético/metabolismo , Obesidad/enzimología , Fosfotransferasas (Aceptor de Grupo Alcohol)/metabolismo , Animales , Activación Enzimática , Glucosa/metabolismo , Insulina/farmacología , Ratones , Fosfatidilinositol 3-Quinasas

RESUMEN

Insulin stimulates the incorporation of glucose-carbon into diacylglycerol (DAG) in rat skeletal muscle, and its ability to do so is enhanced severalfold after the muscle is denervated (S. J. Heydrick, N. B. Ruderman, T. J. Kurowski, H. A. Adams, and K. S. Chen. Diabetes 40: 1707-1711, 1991). The present studies were carried out to assess the nature of this newly synthesized DAG and to identify factors other than insulin that determine its rate of appearance in the incubated rat soleus muscle. In control muscles, incubated at a medium glucose concentration of 6-7.5 mM, insulin (10 mU/ml) increased DAG content (mass) by 20-25% and increased the incorporation of a 14C label from extracellular [14C]glucose into DAG by 200-300%. The labeling of DAG reached a plateau within 20 min, at which time the labeled DAG comprised a very small percentage of total muscle DAG. Molecular species analysis revealed that DAG species having fatty acids of 18:2/20:4 and 18:2/18:2 each constituted approximately 2% of total DAG content but contained 20 and 15%, respectively, of the glucose-derived label in DAG. In contrast, 16:0/18:1 accounted for > 80% of total DAG content but only 18% of the total label incorporated into DAG. Insulin did not alter this pattern. Denervation also did not alter the molecular species profiles of the labeled DAGs or DAG analyzed by mass. An increased incorporation of glucose-carbon into DAG was observed in muscles incubated with 30 mM glucose in place of the usual 7.5-mM concentration.(ABSTRACT TRUNCATED AT 250 WORDS)

Asunto(s)

Diglicéridos/metabolismo , Insulina/farmacología , Músculos/metabolismo , Animales , Carbono/metabolismo , Diglicéridos/química , Espacio Extracelular/metabolismo , Glucosa/metabolismo , Miembro Posterior , Técnicas In Vitro , Masculino , Desnervación Muscular , Concentración Osmolar , Ratas , Ratas Sprague-Dawley

RESUMEN

The effect of okadaic acid, a serine/threonine phosphatase inhibitor, was analyzed in two insulin-responsive systems, the isolated mouse soleus muscle and 3T3-L1 adipocytes. While okadaic acid alone was a potent stimulator of glucose transport in both systems, it prevented transport stimulation by insulin. To gain insight into this inhibitory action, the activation of phosphatidylinositol 3-kinase (PI3-kinase), one of the earliest postreceptor steps identified so far, was studied. In 3T3-L1 adipocytes and muscle, insulin increased PI3-kinase activity in immunoprecipitates obtained with antibodies to phosphotyrosine. Okadaic acid alone had no effect but strongly inhibited this hormonal action. Okadaic acid treatment did not interfere with insulin-induced receptor autophosphorylation or with its tyrosine kinase activity toward artificial substrates. In contrast, in the presence of the phosphatase inhibitor, we did not observe tyrosine phosphorylation of the insulin receptor cellular substrate p185 (IRS-1) or immunoprecipitation of PI3-kinase by antibodies to phosphotyrosine. These results suggest that okadaic acid interferes with insulin's stimulation of glucose transport by inhibiting IRS-1 phosphorylation and its association with PI3-kinase and/or other signaling molecules. However, okadaic acid did not block the insulin stimulation of aminoisobutyric acid uptake in muscle. This would indicate that IRS-1 phosphorylation and PI3-kinase activation are not required for all the effects of insulin and that the serine/threonine phosphorylation events implicated in the translocation of glucose transporters are not controlling amino acid transport in muscle.

Asunto(s)

Aminoácidos/metabolismo , Éteres Cíclicos/farmacología , Glucosa/metabolismo , Insulina/fisiología , Fosfotransferasas/metabolismo , Células 3T3 , Tejido Adiposo/enzimología , Tejido Adiposo/metabolismo , Animales , Transporte Biológico , Masculino , Ratones , Músculos/enzimología , Músculos/metabolismo , Ácido Ocadaico , Fosfatidilinositol 3-Quinasas , Fosforilación , Fosfotransferasas/antagonistas & inhibidores , Receptor de Insulina/metabolismo

RESUMEN

Activation of phosphatidylinositol-3-kinase (PI3K) is one of the earliest postreceptor events in the insulin signaling pathway. Incubation of soleus muscles from lean mice with 50 nM insulin caused a 3-10-fold increase in antiphosphotyrosine-immunoprecipitable PI3K (antiPTyr-PI3K) activity within 2 min in muscle homogenates as well as both the cytosolic and membrane fractions. Insulin did not affect total PI3K activity. Both the antiPTyr-PI3K stimulation and activation of insulin receptor tyrosine kinase were dependent on hormone concentration. In muscles from obese, insulin-resistant mice, there was a 40-60% decrease in antiPTyr-PI3K activity after 2 min of insulin that was present equally in the cytosolic and membrane fractions. A significant reduction in insulin sensitivity was also observed. The defect appears to result from alterations in both insulin receptor and postreceptor signaling. Starvation of obese mice for 48 h, which is known to reverse insulin resistance, normalized the insulin response of both PI3K and the receptor tyrosine kinase. The results demonstrate that: (a) antiPTyr-PI3K activity is responsive to insulin in mouse skeletal muscle, (b) both the insulin responsiveness and sensitivity of this activity are blunted in insulin-resistant muscles from obese mice, (c) these alterations result from a combination of insulin receptor and postreceptor defects, and (d) starvation restores normal insulin responses.

Asunto(s)

Resistencia a la Insulina/fisiología , Ratones Obesos/metabolismo , Músculos/enzimología , Fosfotransferasas/metabolismo , Animales , Diabetes Mellitus Tipo 2/metabolismo , Activación Enzimática/efectos de los fármacos , Insulina/farmacología , Masculino , Ratones , Fosfatidilinositol 3-Quinasas , Fosforilación , Proteínas Tirosina Quinasas/metabolismo , Receptor de Insulina , Transducción de Señal/fisiología , Inanición/fisiopatología

RESUMEN

Denervation induces insulin resistance of the glucose transport process in skeletal muscle. To determine whether this is due to alterations in the expression of muscle glucose transporters (GLUT) in different fiber types, we evaluated the amount of GLUT-1 and GLUT-4 protein and messenger RNA (mRNA) in extensor digitorum longus (EDL) and soleus at 1, 2, and 3 days after sciatotomy. Denervation elevated the basal rate of 2-[1,2-3H]deoxy-D-glucose (2-DOG) uptake in the EDL and decreased the insulin-stimulated DOG uptake in both muscles. Denervation after 1 day did not modify the GLUT-1 or the GLUT-4 protein level in either muscle. However, it increased GLUT-1 mRNA by 66% and decreased GLUT-4 mRNA by 70% in the EDL, but not in the soleus (P < 0.05). After 2 days of denervation, by which time GLUT-1 mRNA was increased 2-fold and GLUT-4 mRNA was reduced by 70%, we observed a 2-fold increase in GLUT-1 protein (P < 0.01) in the EDL and a 40-45% decrease in GLUT-4 protein in both muscles (P < 0.01). These results indicate that modifications in the expression of GLUT-1 and GLUT-4 protein cannot explain the insulin resistance of the glucose transport process in the EDL or soleus 1 day after denervation. After 2 days of denervation, however, alterations in GLUT-1 and GLUT-4 protein levels may contribute to the change in basal and insulin-stimulated DOG uptake in both the EDL and the soleus muscles.

Asunto(s)

Proteínas de Transporte de Monosacáridos/metabolismo , Desnervación Muscular , Proteínas Musculares , Músculos/metabolismo , ARN Mensajero/metabolismo , Animales , Transportador de Glucosa de Tipo 1 , Transportador de Glucosa de Tipo 4 , Masculino , Proteínas de Transporte de Monosacáridos/genética , Ratas , Ratas Sprague-Dawley

RESUMEN

Denervated muscle is generally regarded as insulin resistant because the ability of insulin to stimulate glucose transport and glycogen synthesis is impaired. Previous studies indicate that insulin resistance in these muscles is likely due to a defect at a postreceptor site in the signaling pathway. Because glucose transport into cells has been reported to be linked to changes in diacylglycerol (DAG) and protein kinase C (PKC), we investigated the effect of denervation on the content and synthesis of DAG and the activity and distribution of PKC in the soleus muscle. The DAG content in muscles denervated for 24 h was 40% greater than in control muscles. This was associated with a two- to threefold increase in the percentage of total PKC activity that was membrane associated, with no significant change in total PKC activity, suggesting an increase in PKC activity in vivo. Studies of glucose disposition confirmed that the stimulation of glycogen synthesis by insulin and, to a lesser extent, 2-deoxyglucose uptake were impaired by denervation. However, the stimulation by insulin of glucose incorporation into DAG and other lipids was two- to threefold greater in denervated than in control muscles, and conversion of glucose to lactate and pyruvate and glucose oxidation to CO2 were unchanged. The results reveal a dichotomy in the effects of denervation on various actions of insulin, with both insulin resistance and hyperresponsiveness occurring in different pathways of glucose metabolism. They also reveal a potential mechanism for the elevation of muscle DAG after denervation. The results do not support a direct link between DAG-PKC and glucose transport.(ABSTRACT TRUNCATED AT 250 WORDS)

Asunto(s)

Diglicéridos/metabolismo , Resistencia a la Insulina , Insulina/farmacología , Lípidos/biosíntesis , Desnervación Muscular , Músculos/fisiología , Proteína Quinasa C/metabolismo , Animales , Desoxiglucosa/metabolismo , Técnicas In Vitro , Cinética , Masculino , Músculos/efectos de los fármacos , Músculos/metabolismo , Fosfolípidos/metabolismo , Ratas , Ratas Endogámicas , Nervio Ciático/fisiología

RESUMEN

Past evidence has suggested that the lysosomal pathway is an important site of cytoplasmic RNA degradation in the hepatic parenchymal cell (Lardeux, B. R., Heydrick, S. J., and Mortimore, G. E. (1987) J. Biol. Chem. 262, 14507-14519). We now provide additional support for this notion by quantitating degradable RNA in lysosomes and correlating its pool size with hepatic RNA degradation. Rat livers, previously labeled with [6-14C]orotic acid, were perfused with graded levels of amino acids over the full range of induced autophagy; RNA degradation was determined from [14C]cytidine release. Close correspondence between the marker beta-acetylglucosaminidase and the breakdown of RNA to cytidine in subcellular fractions indicated that the lysosome was the main site of catabolism, a conclusion supported by the fact that degradation was enhanced when external pH was lowered from 7 to 6. Although [14C]cytidine was also released in homogenates by the action of natural ribonucleases on cytosolic RNA, this source was eliminated by unlabeled exogenous RNA. The size of the degradable RNA pool in lysosomes, determined from the total release of cytidine in homogenates, correlated directly with rates of hepatic RNA degradation over the full range of basal and induced degradation. A direct correlation was also seen between RNA degradation and cytidine pools within lysosomal particles. Because cytosolic cytidine was not taken up by lysosomes under these conditions, the pool could only have arisen from the breakdown of intralysosomal RNA. As determined by cytidine production, these findings support the view that the lysosomal-vacuolar system is the main, if not sole, site of induced and basal RNA degradation in liver.

Asunto(s)

Hígado/metabolismo , Lisosomas/metabolismo , ARN/metabolismo , Animales , Citidina/metabolismo , Concentración de Iones de Hidrógeno , Cinética , Masculino , Mitocondrias Hepáticas/metabolismo , Proteínas/metabolismo , Ratas , Ratas Endogámicas Lew , Ribosomas/metabolismo

Asunto(s)

Diglicéridos/metabolismo , Músculos/metabolismo , Proteína Quinasa C/metabolismo , Animales , Glucosa/metabolismo , Técnicas In Vitro , Insulina/farmacología , Resistencia a la Insulina/fisiología , Lípidos/biosíntesis , Desnervación Muscular , Músculos/efectos de los fármacos , Ratas , Transducción de Señal/fisiología

RESUMEN

The control of protein and RNA degradation by amino acids, insulin, and glucagon was investigated in perfused livers from normal fed rats. Rates of breakdown were determined from the release of valine and cytidine after isotopic labelling in vivo. Stringent amino acid deprivation induced comparable increases (approximately 3.2% h-1) in the degradation of both macromolecular classes, and insulin inhibited them equally. By contrast, glucagon evoked the same proteolytic response at normal plasma concentrations but failed to stimulate RNA breakdown significantly. These and associated electron microscopic findings indicate the existence of two concentration-dependent modes of macroautophagy, one which sequesters both RNA and protein at low amino acid levels and a second which selectively takes up protein at normal concentrations. Control of macroautophagy is accomplished by seven regulatory amino acids and the permissive action of alanine. Alanine is required for effective inhibition by the regulatory group at normal concentrations; in its absence protein degradation accelerates sharply. This response, like that following the administration of glucagon, is mediated by the second mode.

Asunto(s)

Autofagia , Hígado/metabolismo , Lisosomas/metabolismo , Fagocitosis , Proteínas/metabolismo , ARN/metabolismo , Aminoácidos/fisiología , Animales , Compartimento Celular , Glucagón/fisiología , Insulina/fisiología , Ratas , Vacuolas/metabolismo

RESUMEN

The breakdown of RNA and of long-lived proteins in rat liver is believed to occur largely within the lysosomal-vacuolar system. Both processes are induced by amino acid lack and suppressed by insulin, and in all circumstances a consistent lag of 15-20 min was observed between the introduction of a physiological regulator and onset of the degradative response. This lag has allowed us to determine rates of liver RNA degradation in vivo during brief cyclic perfusions, as was done previously for long-lived-protein breakdown [Hutson & Mortimore (1982) J. Biol. Chem. 257, 9548-9554]. Degradation was measured from the release of [14C]cytidine in livers of rats previously labelled in vivo with [6-14C]orotic acid. Release was linear and unaffected by physiological regulators between 2 and 12 min of perfusion. In contrast with protein breakdown, no short-lived component was observed. In animals trained to feed between 16:00 and 20:00 h, the content of liver RNA fell at an average rate of 0.26 mg/h per 100 g initial body wt. between 07:00 and 16:00 h, a loss that was within 9% of that predicted from the net release (total release minus reutilization) of cytidine in vivo. In addition, the total rate of RNA degradation determined at the end of the meal was only 12% of that at the start of the post-absorptive period 14 h later (2.1 versus 17.1%/day). This finding is fully consistent with a lysosomal mechanism for RNA degradation, since autophagy is strongly suppressed by food intake. This approach provides a comparatively simple means of approximating moment-to-moment rates of RNA degradation in the rat liver in vivo.

Asunto(s)

Citidina/metabolismo , Hígado/metabolismo , ARN/metabolismo , Aminoácidos/farmacología , Animales , Alimentos , Insulina/farmacología , Masculino , Perfusión , Ratas , Ratas Endogámicas Lew